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The Academy of Science of South Africa (ASSAf) was inaugurated in May 1996 in the 
presence of former President Nelson Mandela, the patron of the launch of the Academy. 
It was formed in response to the need for an Academy of Science consonant with the dawn 
of democracy in South Africa: activist in its mission of using science for the benefit of society, 
with a mandate encompassing all fields of scientific enquiry in a seamless way, and including 
in its ranks the full diversity of South Africa’s distinguished scientists. 
The Parliament of South Africa passed the Academy of Science of South Africa Act (Act 67 
of 2001), as amended, and the Act came into force on 15 May 2002. This has made ASSAf 
the official Academy of Science of South Africa, recognised by government and representing 
South Africa in the international community of science academies.
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2FOREWORD
Agricultural biotechnology, specifically genetic modification (GM) technology, has the 
potential to contribute to poverty reduction and food security on the African continent. 
Increased crop productivity and increased adaptation to drought and pests are some of the 
benefits. Yet Africa has been slow to reap the benefits of GM crops. The main objective of 
this policymakers’ booklet is to provide science-based information that will encourage safe 
access to GM technology.
It focuses on ways that could improve the efficiency and quality of policy development for 
GM technology, as well as on building African policymakers’ confidence by suggesting 
effective ways of procuring and using scientific evidence in GM risk analysis. It also focuses 
on the role of the public; the African national science academies and science-related 
associations in GM regulatory systems and processes. The key messages are on how this 
scientific advice can be procured from reputable organisations/institutions such as African 
national science academies. Using transparent, inclusive institutional mechanisms to engage 
the public in GM technology regulatory processes are also recommended.
Given their role of providing evidence-based scientific advice to government and increasing 
public awareness of science, national science academies in Africa are well placed to take up 
the challenge of providing evidence-based advice on GM crops. The booklet is a guide to 
African policymakers on how they can procure and use evidence to make informed decisions 
on the development, introduction, commercialisation and use of agricultural GM technology.
ASSAf acknowledges Professor John Mugabe for compiling this booklet and the many 
reviewers, whose contributions have added considerable value to the content. The Mauritius 
Academy of Science and Technology (MAST) is acknowledged for their contribution and 
for hosting the collaborative workshop. The Global Network of Science Academies (IAP) is 
thanked for funding this project.
Prof Roseanne Diab
Executive Officer: Academy of Science of South Africa
3ACRONYMS
aaS African Academy of Sciences
aatf African Agricultural Technology 
Foundation
aBne African Biosafety Network of 
Expertise
acgt African Centre for Gene 
Technologies
ageRi Agricultural Genetic Engineering 
Research Institute
aRc Agricultural Research Council
aSSaf Academy of Science of South 
Africa
au African Union
Bt Bacillus thuringiensis
cgiaR Consultative Group on 
International Agricultural Research
cSiR Council for Scientific and 
Industrial Research
Dna Deoxyribonucleic acid
eaSac European Academies Science 
Advisory Council 
eu European Union
faBi Forestry and Agricultural 
Biotechnology Institute (University 
of Pretoria)
fao United Nations Food and 
Agriculture Organisation
gDP Gross domestic product
gM Genetically modified/genetic 
modification
gMos Genetically modified organisms
ha Hectare
hiV/ 
aiDS
Human immunodeficiency virus/
Acquired immunodeficiency 
syndrome
iaP Global Network of Science 
Academies
iSaaa The International Service for 
the Acquisition of Agri-biotech 
Applications
ineRa National Agricultural Research 
Institute (Burkina Faso)
KaRi Kenya Agricultural Research 
Institute
kg Kilogram
MaSt Mauritius Academy of Science and 
Technology
MDg Millennium Development Goal
naSac Network of African Science 
Academies
nBa National Biosafety Agency
nePaD New Partnership for Africa’s 
Development
oecD Organisation for Economic 
Co-operation and Development
R&D Research and development
SaSRi South African Sugarcane Research 
Institute
un United Nations
unaS Uganda National Academy of 
Sciences 
uP University of Pretoria 
uSa United States of America
4INTRODUCTION
This policymakers’ booklet is produced by 
the Academy of Science of South Africa 
(ASSAf) as part of the project “GMOs 
for African Agriculture: Opportunities and 
Challenges”. The project was implemented 
through ASSAf’s Committee on Science 
for Poverty Alleviation. The project is in 
its second year of implementation with 
funding from the Global Network of 
Science Academies (IAP).
ASSAf has a mandate to give independent 
and non-biased, evidence-based advice to 
government/policymakers and the public/
society on issues that are of interest to 
the South African nation and beyond. 
Prior to compiling this booklet ASSAf, in 
collaboration with the Mauritius Academy 
of Science and Technology (MAST), held a 
joint workshop on policy and institutional 
challenges to the development, regulation 
and commercialisation of agricultural 
GMOs in Africa. The workshop, 
which took place on 7 June 2011 in 
Mauritius, was attended by participants 
and speakers from across the African 
continent. Participants shared information 
on the status of GM research and 
commercialisation activities in the countries 
of the four African regions (north, south, 
east and west). They discussed factors 
that are contributing to the slow rate of 
commercialising GMOs in Africa and 
made suggestions for institutional capacity 
building to improve regulatory systems. 
This booklet builds on the discussions and 
suggestions made at the workshop. It 
highlights the key opportunities of genetic 
modification in agriculture, and policy 
and institutional challenges in regulating 
the development, introduction and 
commercialisation of GMOs. The booklet 
places emphasis on the importance of 
African policymakers procuring and using 
credible scientific evidence and expertise 
from academies in order to make accurate 
and timely decisions on GM technology 
to ensure its effective and sustainable 
5utilisation. It also discusses the importance of 
mobilising science academies and scientific 
evidence and ensuring public participation in 
GM technology regulatory processes.  
KEY MESSAGES FOR 
POLICYMAKERS
1. Agricultural biotechnology can help to 
transform Africa’s agriculture, increase 
food production and enable African 
communities to adapt to climate change 
if african governments establish and 
use efficient technology regulatory 
systems where appropriate. efficient 
regulatory systems must be predictable; 
they should promote innovation, as 
well as the diffusion and utilisation of 
agricultural biotechnology.
2. The regulation of agricultural 
biotechnology, in general, and genetic 
modification, in particular, is knowledge 
intensive and should be based on 
peer-reviewed evidence obtained from 
hypothesis-based testing.
3. African policymakers should ensure 
that they procure and use robust 
evidence-based, peer-reviewed 
scientific information and advice when 
making decisions on the development, 
introduction, commercialisation and 
importation of genetically modified 
organisms (GMOs).
4. African national and regional science 
academies are sources of credible and 
independent scientific expertise and 
advice on agricultural biotechnology. 
Policymakers should seek to engage 
African academies when making 
decisions on the regulation of agricultural 
biotechnology.
5. In addition to science, public participation 
is necessary to instil confidence among 
stakeholders about GM technology 
decision-making. African policymakers 
should create and use transparent, 
as well as inclusive institutional 
mechanisms to engage the public in gM 
technology regulatory processes.
6. national policies and laws on 
agricultural biotechnology can only be 
successfully and effectively implemented 
if there is real political will and conviction. 
Policymakers and regulators should also 
be able to publicly defend their decisions 
on GM technology.
CONTEXT: AGRICULTURE AND 
AFRICAN DEVELOPMENT
Africa is vividly confronted by a paradox: 
food insecurity in an era of rapid 
technological advances in agriculture. While 
the rest of the developing world is purposely 
engaged in the development and application 
of modern agricultural biotechnologies, such 
as GM technology, Africa is held back and 
continually preoccupied with the old debate 
on the role and safety of technology in food 
production and sustainable development. 
The mixed response to GM technology 
by European Union (EU) countries and 
the negative political sentiment in the EU, 
Africa’s major trade partner, has undoubtedly 
influenced the political acceptance process in 
Africa. However, it is important that decision-
making in Africa takes account of the local 
situation and that it is made for Africa.
The continent is exposed to:
• a wide range of scientific applications 
or techniques to improve crop varieties 
and livestock production through genetic 
modification; and
• a pool of scientific knowledge and 
innovations for conserving biological 
diversity and addressing the challenges 
of climate change. 
Yet, Africa is failing to effectively harness and 
use new knowledge and innovations to fight 
hunger, eliminate malnutrition and achieve 
higher levels of human development. More 
than 25 million people are food insecure 
and exposed to ecological catastrophes 
such as drought and floods in africa.
6Agriculture is Critical to Attaining 
the MDGs in Africa
The extent to which Africa will attain 
the United Nations (UN) Millennium 
Development Goals (MDGs), and 
the MDG 1 (eradicate poverty and 
hunger) in particular, is dependent 
on improvements in agricultural 
productivity. Agriculture is the foundation 
of Africa’s social, political and economic 
systems. It is the source of livelihoods, 
political stability and the growth of 
national economies. Agriculture provides 
employment to 65 percent of Africa’s 
population and accounts for at least 
30 percent of the gross domestic 
product (GDP) of the continent. Women 
constitute at least 50 percent of the 
labour force in African agriculture. Thus, 
improvements in agricultural productivity 
are likely to promote the achievement of 
MDG 3 (promote gender equality and 
empower women). The productivity of 
agriculture will also determine the extent 
to which other MDGs are attained in 
Africa.
However, African agriculture is 
underdeveloped and is not being 
used adequately to expand human 
capabilities and create opportunities for 
relief of poverty. Agriculture in Africa, 
particularly in sub-Saharan Africa, is 
rain-fed, largely on a subsistence or 
small-scale level and produces yields 
much lower than those achieved in 
more advanced agricultural systems. 
It lacks infrastructure and institutional 
sophistication and is less mechanised 
when compared to the United 
States, Europe, Asia and even Latin 
America. It can be argued that the 
underdevelopment of the continent’s 
agriculture is one of the primary reasons 
for the continuing situation of food 
insecurity and poverty.
In comparison with other regions in the 
world, agricultural growth has been slow 
in Africa. For example, the yield gap 
for cereals between sub-Saharan Africa 
and other regions has widened over the 
past two decades or so. “Cereal yields 
in Africa have grown little and are still 
at around 1.2 tonnes per hectare (ha), 
compared to an average yield of some 
3 tonnes per hectare in the developing 
world as a whole. Fertiliser consumption 
was only 13 kg/ha in sub-Saharan 
Africa in 2002, compared to 73 kg/ha 
in the Middle East and North Africa and 
190 kg/ha in East Asia and the Pacific.”1 
According to the UN Food and 
Agriculture Organisation’s (FAO) State 
of Food and Agriculture 2010–2011, 
sub-Saharan Africa:
• is home to 26 percent of the world’s 
undernourished population;
• has the highest number of countries 
experiencing food emergences due, 
in part, to climate extremes such as 
drought and exacerbated by civil 
unrest;
• experienced increased food imports 
during the first half of this decade; 
and
• is very vulnerable to global food 
price increases.
The poor performance of the agricultural 
sector undermines Africa’s prospects 
of attaining the MDGs and sustainable 
development in general. It also makes 
the continent more vulnerable to impacts 
of climate change and global financial 
crises. The low agricultural productivity 
is associated with a wide range of 
factors, including low investments in 
education, infrastructure, research and 
development (R&D) and over-reliance 
on conventional technologies.2 The 
application of the best of conventional 
agricultural technologies can make a 
significant contribution to improving 
food security, but on its own will not 
solve the immense food production 
challenges that the African continent 
faces. The expansion of cultivated land 
through mechanisation and provision 
7of fertilisers can make a positive impact on 
food security in Africa, but further benefits 
can be achieved by the application of 
modern biotechnology methods to plant- 
improvement programmes, principally for 
the so-called ’orphan crops’ of particular 
importance to Africa.
The under-representation of the private 
sector in agriculture in Africa needs 
attention. In most parts of the world, the 
private sector is driving ‘cutting-edge’ R&D 
in agriculture. In Africa, the opposite is true. 
African governments need to encourage a 
positive investment climate for external, as 
well as internal, private sector participation 
in agricultural R&D. This can be achieved 
through the introduction of enabling policies, 
including a clear regulatory framework 
and intellectual property protection, that 
encourage private sector investment.
Key Message for Policymakers
African countries should increase 
investments in R&D and relevant 
technological innovations in agriculture. 
Increased agricultural production and food 
security will come through technological 
innovations, coupled with education, and 
not from mere provision of traditional farm 
inputs.
African governments should create a 
positive investment climate for private sector 
participation in agricultural R&D.
AGRICULTURAL 
BIOTECHNOLOGY: GLOBAL 
TRENDS AND OPPORTUNITIES
Agricultural biotechnology, including 
genetic marker-assisted conventional plant  
breeding, and GM technology in particular, 
holds great promise of helping to transform 
Africa’s agriculture. In much of the world, 
the application of technology is making it 
possible to break barriers to increased food 
production by increasing yields, decreasing 
crop losses to pests and disease, both pre- 
and post-harvest, and developing crops 
that are more able to withstand/tolerate the 
Role of Agriculture in the Attainment of MDGs
“While the linkage with agriculture is particularly strong for the first MDG, or MDG 1 – 
halving by 2015 the proportion of those suffering from extreme poverty and hunger – all 
MDGs have direct or indirect linkages with agriculture. Agriculture contributes to MDG 1 
through agriculture-led economic growth and through improved nutrition. In low-income 
countries, economic growth, which enables increased employment and rising wages, is 
the only means by which the poor will be able to satisfy their needs sustainably. MDG 2, 
on universal education: A more dynamic agricultural sector will change the assessment of 
economic returns to educating children, compared to the returns from keeping children out 
of school to work in household (agricultural) enterprises. Agriculture contributes to MDG 3 
directly through the empowerment of women farmers and indirectly through reduction of the 
time burden on women for domestic tasks. Agriculture contributes to reduced child mortality 
(MDG 4) indirectly by increasing diversity of food production and making more resources 
available to manage childhood illnesses, particularly those caused by micronutrient deficiency. 
Agriculture directly helps improve maternal health (MDG 5) through more diversified food 
production and higher quality diets, and indirectly through increased incomes and, thus, 
reduced time burdens on women. Agriculture also directly helps to combat HIV/AIDS, 
malaria, and other diseases (MDG 6) through higher quality diets, and indirectly by providing 
additional income that can be devoted to health services and education. Agriculture practices 
can be both direct causes of and important solutions to environmental degradation (MDG 7). 
More productive agricultural technologies allow the withdrawal of agriculture from marginal, 
sensitive environments. Developing a global partnership for development (MDG 8) will help 
maintain the steady increase in agricultural trade and significant increases in development 
assistance offered to the agricultural sector, increases that help sustain the benefits from 
agriculture in the longer term.”
Source: www.ifpri.org/publication/agriculture-and-achieving-milliennium-development-goals 
8extremes of climate. New varieties of crops 
and livestock vaccines are being developed 
and made available to farmers around 
the world in unprecedented ways. This 
technology and its application are:
• science intensive – capabilities in 
scientific fields, such as molecular 
biology, biochemistry, physiology 
and synthetic biology, are critical 
for successful engagement with and 
application of the technology; and
• pervasive – the knowledge and 
techniques can be applied across 
economic sectors. For example, 
techniques developed for and applied 
in crop improvement can also be 
applied in the conservation of genetic 
resources and improvement of forests.
GM crops were first used commercially in 
1996, and since then have been rapidly 
adopted by most of the major agriculturally 
advanced countries in the world. It is 
“the stable, heritable modification of an 
organism’s genetic makeup via asexual 
gene transfer, regardless of the origin 
and nature of the introduced gene.”3 For 
example, a gene from a common soil 
bacterium that occurs in nature can be 
inserted into cotton to produce a variety 
which confers resistance to insect pests 
such as the cotton bollworm. 
GM technology may also involve modifying 
a plant’s own genes through gene-splicing 
(i.e. the technology of changing the 
organism’s genetic traits by rearranging 
specific pieces of its DNA in vitro). The 
introduction of regulatory DNA sequences 
which control gene expression can, for 
example, increase or decrease the activity 
or expression of certain genes already in 
the organism themselves, thus modifying 
beneficial agricultural traits in the mature 
crop. 
GM is increasingly based on the 
application of a growing understanding 
9of how the genetic information found in 
the plant defines those traits of benefit, 
with second generation GM crops 
being developed to address quality, 
nutrition, processing and value-added 
traits. This information is derived from a 
combination of new techniques, particularly 
genomics, proteomics, metabolomics and 
bioinformatics, which allow scientists to 
develop a far more comprehensive image 
of the metabolic and physiological impacts 
of an individual genetic trait. A genetically 
modified organism (GMO) is the product of 
the process of genetic modification.
Key Message
GM technology makes it possible to develop 
crops with useful traits when conventional 
breeding techniques are not able to develop 
such traits. It offers great potential for 
enhancing the productivity of crops and 
food quality by increasing their resistance 
to biotic and abiotic stresses, improving 
their post-harvest characteristics and/or 
enhancing their nutritional composition.
The first GM crop was released for 
commercial use in the United States of 
America (USA) in 1996. It was a tomato 
(called FlavrSavr) that was genetically 
modified to not ripen on the vine but only 
once it reached the market, to protect it from 
post-harvest damage. Since its introduction, 
the adoption of GM crops has advanced 
rapidly around the world, particularly in 
Asia, Latin America and North America. In 
2011, the cultivation of these crops reached 
a total of 160 million ha in 19 developing 
and 10 developed countries.4 Almost  
17 million farmers, of which 90% are 
small resource-poor farmers in developing 
countries, are growing biotech crops. 
Overall, in 2011, the developing countries’ 
global contribution of biotech crops was 
almost 50 percent and it is anticipated that 
they will surpass the industrial countries’ 
hectarage in 2012.5    
In terms of regional outlook of GM crop 
cultivation and adoption, in 2011:
• north america: the USA is still 
the leading producer of GM crops, 
accounting for 69 million ha (43 percent 
of global production). Canada is ranked 
fifth in the world;
• europe: contrary to commonly held 
misconceptions, six European Union (EU) 
countries (Spain, Portugal, Romania, 
Czech Republic, Poland and Slovakia) 
cultivated 114 490 ha of Bt maize, a  
26 percent increase from 2010;
• latin and South america: Brazil is 
ranked second to the USA with Argentina 
ranked third. Other countries include 
Paraguay, Mexico, Colombia, Chile, 
Uruguay and Cuba;
• asia: China, India, Myanmar, Philippines, 
Iran and Pakistan cultivated GM crops;
• africa: Burkina Faso, Egypt and South 
Africa (with South Africa being the ninth 
largest producer overall).5 
Although Burkina Faso, Egypt and South 
Africa are currently the only African 
countries that commercially cultivate GM 
crops, advanced field trials have also been 
conducted in Kenya, Nigeria, Uganda and 
Zimbabwe. 
GM Traits Targeted 
Currently the major agronomic traits 
targeted through GM are insect resistance 
and herbicide tolerance. The crops of focus 
are maize, cotton, soybean and rapeseed/
canola. In 2009, these crops accounted for 
more than 50 percent of all GM crops under 
commercial cultivation around the world. 
Future and Ongoing GM 
Developments
A growing number of other crops and 
plants are being tested with various GM 
traits, including potato, beet, tobacco, rice, 
barley, wheat, sugarcane and eucalyptus. In 
addition, a number of previously neglected 
10
figure 1: Biotechnology crops’ statistics for 2011 (James, 2011)4  
5 Canada*
10.4 mil ha
canola, maize, 
soybean, sugarbeet
1 USA*
69.0 mil ha
maize, soybean, cotton, 
canola, sugarbeet, alfalfa 
papaya, squash
16 Mexico*
0.2 mil ha
cotton, soybean
20 Honduras
<0.05 mil ha
maize
18 Colombia
<0.05 mil ha
cotton
28 Costa Rica
<0.05 mil ha
cotton, soybean
10 Uruguay*
1.3 mil ha
soybean, maize
11 Bolivia*
0.9 mil ha
soybean
7 Paraguay*
2.8 mil ha
soybean
19 Chile
<0.05 mil ha
maize, soybean, 
canola
3 Argentina*
23.7 mil ha
soybean, maize, 
cotton
2 Brazil*
30.3 mil ha
soybean, maize, 
cotton
21 Portugal
<0.05 mil ha
maize
15 Burkina Faso*
0.3 mil ha
cotton
17 Spain*
0.1 mil ha
maize
29 Germany
<0.05 mil ha
potato
27 Sweden
<0.05 mil ha
potato
24 Egypt
<0.05 mil ha
maize
22 Czech Republic
<0.05 mil ha
maize
23 Poland
<0.05 mil ha
maize
26 Romania
<0.05 mil ha
maize
25 Slovakia
<0.05 mil ha
maize
6 China*
3.9 mil ha
cotton, papaya, 
poplar, tomato, 
sweet pepper
14 Myanmar*
0.3 mil ha
cotton
9 South Africa*
2.3 mil ha
maize, soybean, 
cotton
12 Australia*
0.7 mil ha
cotton, canola
4 India*
10.6 mil ha
cotton
8 Pakistan*
2.6 mil ha
cotton
13 Philippines*
0.6 mil ha
maize
* 17 biotech mega-countries growing 50 000 hectares, or more, of GM crops
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so-called ‘orphan crops’, such as cassava, 
pigeon pea, banana and sweet potato, 
which are important staples in many African 
countries, are also being improved by both 
conventional breeding and GM. Forage 
crops are also receiving significant attention 
and several species have already been 
evaluated in field trials. GM alfalfa has 
already been commercialised in the USA 
and Canada. 
New lines of GM maize, soybean, cotton 
and rapeseed are still being developed. By 
2015, it is predicted that there will be:
• five lines of GM soybean with herbicide 
resistance traits compared to three in 
2008;
• nine varieties of GM soybean with pest 
resistance in 2015 compared to one in 
2008.6 
Key Messages for Policymakers
The International Service for the Acquisition 
of Agri-Biotech Applications (ISAAA) 
reported that there has been a 94-fold 
increase in hectarage from 1.7 million ha 
in 1996 to 160 million ha in 2011. They 
concluded that this makes biotech crops the 
fastest adopted crop technology in modern 
agriculture history. 
In the 16-year period (1996–2011), millions 
of farmers cultivated and re-cultivated over 
1.5 billion ha (accumulated) of biotech 
crops. This indicates that biotech crops 
provided substantial, sustainable, socio-
economic and environmental benefits for 
these farmers.
Source: ISAAA Brief 43-2011
Farmers’ Pragmatism
“Growers around the world are facing 
challenging economic hardships, trapped 
somewhere between rising prices for 
input costs and increasing yields and 
unpredictable prices for their crops. For 
most farmers, (...) issues about technical 
use agreements, patent rights, and 
multinational corporate politics pale beside 
the pragmatic concern of producing a 
crop whose bottom line will not be red. 
Producers view the environmental and 
food safety risks of GM crops as small to 
nonexistent, and see diversification of GM 
products as the only viable way to increase 
farm income and profits.”
Source: Winston (2002) Travels in the Genetically 
Modified Zone, p.149. Harvard University Press
African policymakers should also note that 
farmers are pragmatic. If GM technology 
can improve quality of life, food production 
and economic profitability, they can and will 
adopt it if given the opportunity. 
Debate on Risks and Benefits of GM 
Crops
Over the past two decades or so there has 
been debate on the impact of biotechnology 
in general and GMOs in particular. The 
debate on risks of GMOs has generally 
focused on environmental, health and socio-
economic impacts. In terms of environmental 
impacts or risks, emphasis has been 
placed on non-target effects and potential 
negative impacts on biological diversity. 
Potential negative impacts on human and 
animal health focus on possible toxicity and 
allergenicity effects. There are now numerous 
studies that show environmental and health 
benefits of agricultural biotechnology and 
GM crops.7 
Environmental 
The introduction of GMOs into the 
environment is perceived that it will destroy 
indigenous species, lead to the loss of 
biological diversity or be invasive. However, 
a multitude of scientific studies have 
demonstrated that the current, commercially 
cultivated GMOs should be no more or less 
invasive than their conventional counterparts. 
In fact, a number of studies have 
demonstrated the environmental benefits of 
these GM crops. For example, a study by 
Woldenbarger and Phifer (2000) concluded 
that: “In 1998, 8.2 million fewer pounds of 
active pesticide ingredient (3.5%) were used 
on corn, cotton, and soybeans than in 1997 
and corresponded to an increase in the 
adoption of genetically engineered crops.”8 
Another study by Qaim (2009) estimated 
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that: “between 1996 and 2006 Bt cotton 
was responsible for global savings of 128 
million kg of pesticide active ingredients, 
reducing the environmental impact of total 
cotton pesticides by 25%.”9 According to 
ISAAA (2011) “the accumulative reduction 
in pesticides for the period 1996–2010 was 
estimated at 443 million kilograms (kgs) of 
active ingredient.” 
This translates to a 17.9% reduction in the 
associated environmental impact of the use 
of pesticide on these crops.5  
Key Message for Policymakers
The potential environmental risks of 
GMOs must be evaluated against their 
demonstrated environmental benefits. 
Environmental benefits of GMOs are 
documented, for example, insect-resistant 
GM crops may decrease the use of agro-
chemicals. 
Food/feed safety
GM food and feed safety is ensured 
through a number of international and 
national regulations and guidelines with the 
purpose to ensure that GM crops are safe 
for human and animal consumption. Food/
feed safety assessments are comprehensive 
and include comparative molecular, 
genetic, metabolic and chemical analyses. 
They also consider the direct impacts 
and the possible secondary effects of the 
introduced GM intervention.10 
The main objective of these food safety 
assessments is to give science-based proof 
that GM foods and feeds are safe. Food 
safety assessments are typically done on a 
case-by-case basis as it is not possible to 
make general conclusions for all possible 
GM crops.10 
Current food safety assessments have 
been proven to be adequate since no 
adverse effects to human and animal 
health have been documented since the 
commercialisation of GM foods more 
than 15 years ago. GM foods/feeds are 
vigorously assessed to ensure they are as 
safe as their conventional counterparts.
13
Key Message for Policymakers
Health benefits of GM crops include farmers’ 
reduced exposure to insecticides and 
pesticides, lower pesticide residues in water 
and food, and lower levels of mycotoxins in 
maize.
Socio-economic 
A number of studies have been conducted to 
assess the possible socio-economic impacts 
of the adoption of GM crops.11 These studies 
show that if appropriate policy incentives 
and institutional arrangements are put in 
place, both small-scale and large-scale 
farmers adopt GM crops. On the economics 
of Bt cotton and maize adoption, a study 
conducted by Qaim (2009) concluded 
that there are agronomic and economic 
benefits.9 According to the ISAAA (2011) a 
total of 16.7 million farmers grew biotech 
crops in 2011 and 15 million of these (90%) 
were small, resource-poor farmers from 
developing countries. Small farmers are thus 
economically benefiting disproportionately 
more.5 
DEVELOPMENT AND ADOPTION 
OF GM CROPS IN AFRICA
Since the introduction of GM technology 
and commercialisation of the first GM crop 
in the world, few African countries have 
actively invested in research, technology 
development and the adoption, as well as 
commercialisation of GM crops. This is in spite 
of the declining agricultural production and 
increasing food insecurity on the continent.
Africa’s investment in crop genomics 
research is insignificant on a global scale. A 
recent study on funding of basic research in 
biotechnology demonstrated that South Africa, 
Africa’s leading adopter of GM technology, 
accounts for an insignificant amount of global 
total expenditure on GM crop research. South 
Africa’s investment in biotechnology R&D in 
general and genomics in particular is still low 
when compared to countries such as China, 
India, Brazil and South Korea.12 
GM Crop Research and Field Trials in 
Africa
Most of the scientific research on GM in 
agriculture in Africa is conducted in public 
universities in South Africa, and in some 
national agricultural research institutes in 
South Africa, Nigeria, Kenya, Egypt, Uganda 
and Mauritius. There is also GM crop research 
being undertaken by international and 
regional organisations based in Africa. Most 
of the research activities are documented in 
recent studies.13 Below is an overview of some 
of the GMO research activities in Africa.
South Africa
table 1 (page 14) provides an overview 
of GM crop research in South African 
universities.
GM crop research is conducted by the 
Agricultural Research Council (ARC). The 
ARC’s Biotechnology Division is conducting 
research to develop GM potato, soybean, 
strawberries, apples, sweet potato, 
Amaranthus and Vigna varieties that are 
resistant to drought and high temperatures.
The Council for Scientific and Industrial 
Research (CSIR) is another key public R&D 
institution that is engaged in research to 
develop GM crops. The CSIR, in collaboration 
with the University of Pretoria (UP), established 
the African Centre for Gene Technologies 
(ACGT) – a world-class platform of facilities 
for genomics research. The Centre is 
coordinating research on cassava genomics.
The CSIR, in collaboration with the ARC, 
Africa Harvest, UP and Pioneer Hi-Bred (a 
private company), has also been conducting 
research to enhance the nutritional content of 
sorghum through GM. The research focuses 
on developing GM sorghum varieties with 
enhanced essential amino acids (particularly 
lysine, threonine and tryptophan) vitamins A 
and E, iron and zinc. Approval for contained 
trials was granted to the CSIR in 2009. Other 
CSIR research activities have focused on 
developing GM tobacco, maize and millet. 
The South African Sugarcane Research 
Institute (SASRI) has done work on GM 
sugarcane. 
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table 1: overview of gM crop research in South african universities
Institution Overview of research
University of Cape Town, 
Department of Molecular and 
Cell Biology
Genetic modification of maize (development of maize streak 
virus resistant maize, as well as drought tolerant maize), 
characterisation of novel components of the plant immune system 
and histidine biosynthesis in plants, and research in genetic 
diversity and molecular biology of single-stranded DNA viruses
University of Pretoria, Forestry 
and Agricultural Biotechnology 
Institute (FABI)
Cereal genomics, forest molecular genetics, molecular plant 
physiology, comparative genomics, phylogenetic studies linked to 
diagnostics, and gene discovery linked to disease resistance and 
drought tolerance of crops
University of the Witwatersrand 
(Wits), Department of Plant 
Biotechnology
Mass production of plants using somatic embryogenesis 
techniques. Somatic embryos are used in both genetic 
transformation and cryopreservation studies
University of Stellenbosch, 
Institute for Plant Biotechnology
Understanding of carbohydrate partitioning in plant organs of 
strawberry, tomato and grapevine; identification of novel genes 
coding for biopolymer synthetics or modifying enzymes; and 
understanding of plant growth using proteomic and transcriptomic 
analysis
University of the Free State High-throughput analysis of proteins and enzyme assays, 
including proteome analysis, and the screening of plant extracts 
for activating activities for specific enzymes. Research on analysis 
of gene expression microarrays and genomics distribution studies, 
particularly the relationship between the genomic distribution of 
specific proteins or post-translational modifications of proteins
Source: Based on a questionnaire sent to 10 universities in South Africa. Responses from the five universities 
not listed above focused mainly on health biotechnology research
Egypt
The main public R&D institute involved 
in scientific research on GM crops is the 
Agricultural Genetic Engineering Research 
Institute (AGERI). The AGERI has research 
activities to produce:
• GM melon resistant to viruses;
• GM tomato resistant to tomato yellow 
leaf curl virus; and
• GM potato resistant to potato leaf roll 
virus. 
Mauritius
GM research in Mauritius is largely 
concentrated on the development of 
sugarcane. Although no field trials have 
been conducted, research has led to the 
development of sugarcane with herbicide 
resistance. There is also ongoing research 
to develop GM sugarcane that is resistant 
to drought in Mauritius. The lack of field 
trials is mainly because of the failure to 
fully promulgate the country’s GMO Act of 
2004 and enact specific regulations for the 
implementation of the legislation.
Kenya 
Research on GM crops is mainly undertaken 
by the Kenya Agricultural Research 
Institute (KARI). KARI is collaborating with 
international institutes of the Consultative 
Group on International Agricultural 
Research (CGIAR) and private companies to 
undertake research. Most of its work on GM 
crops is in the form of contained and field 
trials. 
In general, there is less scientific or basic 
research on GM crops in Africa. Most of the 
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activities focused on applied research with 
emphasis on field trials. table 2 provides 
an overview of countries that have invested 
in GM crop field trials. 
Adoption of GM Crops in Africa
Using acreage of cultivated GM crops as 
an indicator of the extent of adoption, 
South Africa, Burkina Faso and Egypt 
are the leading adopters of agricultural 
biotechnology in Africa. In 2011, Egypt 
had less than 0.1 million ha of Bt maize, 
Burkina Faso had 0.3 million ha under Bt 
cotton, and South Africa, 2.3 million ha 
under GM maize, soybean and cotton.5  
table 2: Recorded field trials of gM crops in africa
Country GM crop
Burkina Faso Bt cotton (approved for commercialisation), cowpea (insect resistance) 
and sorghum (biofortified) 
Egypt Maize, (insect resistance; approved for commercialisation), cotton 
(salt tolerance), wheat (drought tolerance), potato (viral resistance), 
cucumber (viral resistance), melon (viral resistance) and tomato (viral 
resistance) 
Kenya Maize (insect resistance), maize (Striga resistant), maize (drought 
tolerance), cotton (insect resistance), cassava (viral resistance), sweet 
potato (viral resistance) and sorghum (biofortified) 
Mozambique Maize (drought tolerance)
Nigeria Cassava (nutrient enhancement), cowpea (Maruka insect resistance), 
sorghum (biofortified) 
South Africa Maize (drought tolerance), maize (herbicide tolerance), maize (insect 
resistance), maize (insect and herbicide tolerance), maize (viral 
resistance), potato (insect resistance), cotton (insect and herbicide 
tolerance), soybean (herbicide tolerance), sugarcane (insect and 
herbicide tolerance), sugarcane (viral resistance, increased yields and 
alternative products), cassava (biofortified), cassava (modified starch), 
sorghum (biofortified) 
Uganda Banana (fungal resistance), banana (biofortified), maize (drought 
tolerance), maize (Striga resistance), Bt cotton (insect resistance), 
cotton (herbicide tolerance), cassava (viral resistance), cassava (insect 
resistance) and sweet potato (weevil resistance) 
Zimbabwe Cowpea (insect resistance)
Sources: AU/NEPAD African Biosafety Network of Expertise (ABNE) database; interviews;  
http://www.nepadbiosafety.net; http://bibliosafety.icgeb.org/  
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figure 2: Number of general release permits issued in South Africa (Biosafety South 
Africa, 2012)10
Burkina Faso
In 2008, Burkina Faso approved Bt cotton 
for commercial cultivation after six years 
of field trials. In early 2011, Bt cotton was 
cultivated on about 250 000 ha of land.14 
Based on the successful introduction 
and adoption of Bt cotton, the National 
Agricultural Research Institute (INERA) of 
Burkina Faso and the African Agricultural 
Technology Foundation (AATF) have started 
field trials of Bt cowpea. In addition, Burkina 
Faso’s National Biosafety Agency (NBA) 
is reviewing an application for testing 
and commercial approval of biofortified 
sorghum.
South Africa
South Africa has the largest commercial 
application of GM crops in Africa. The first 
GM crop field trials started in 1992 and the 
first approved commercial application was in 
1997. In 2011 the acreage under GM crops 
was estimated at 2.3 million ha.5 There has 
since been a total of 13 general release 
permits with four of them for maize, eight 
for cotton and one for soybean (figure 2). 
The GM traits introduced to these crops are 
either insect resistance, herbicide tolerance 
or both.10 
Commodity clearance, where GM grains 
are imported for food and feed (and not 
for cultivation), is an important aspect in 
the trade of GM foods. GM importing 
countries need regulatory measures in place 
that deal with approval processes involved 
in obtaining these clearance commodity 
permits.15 South Africa, a couple of years 
after implementing the GMO Act, introduced 
commodity clearance for a variety of GM 
products after safety review.16 The country 
now has full approval procedures in place 
for commodity clearance under the GMO 
Act and the Act also has procedures for 
exportation of GM products. 
Key Message 
Despite the increasing adoption rate and 
benefits of GM crops, less than fifteen 
African countries have approved field trials 
and only three countries have GM crops 
approved for cultivation and commercial 
use.
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Challenges to the Adoption of 
Agricultural Biotechnology and GM 
Crops
The low uptake or adoption of agricultural 
biotechnology in general and GM crops in 
particular is associated with the following 
factors:
1. Inadequate investment in scientific 
research and promotion of innovation
 In spite of the documented benefits (i.e. 
environmental, economic and health), 
Africa is not investing adequate resources 
to adopt and promote the diffusion of 
agricultural biotechnology and its GM 
products. GM crops (for example cassava, 
potato, maize and cowpea) of high 
importance in terms of food security are 
taking unnecessarily long in the pipeline 
of contained laboratory and field trials in 
some African countries.
2. Policymakers’ indecisiveness
 
 The low adoption, diffusion and 
commercialisation of GM crops in Africa are 
also associated with policy uncertainty and the 
indecisiveness of african leadership. Many 
African policymakers are often confronted with 
opposing views or positions on the role and 
impacts of GMOs in agriculture. They are often 
left irresolute after listening to the opposing 
views of pro-GMO and anti-GMO groups. 
Their tendency is to either suspend decision-
making, or to transfer the responsibility of 
making decisions on whether to accept or reject 
the introduction of GMOs into agriculture to 
relatively junior officers in regulatory offices. In 
many cases these offices do not have adequate 
resources to procure the best available science-
based advice. 
3. Passive participation of African scientists and 
science associations
 In most African countries, scientists with 
knowledge of GM and information on GM 
crops are not actively engaged in raising 
public awareness of the benefits of the 
technology. They are also not actively engaging 
policymakers to promote informed decision-
making. Associations of microbiologists, plant 
geneticists and science academies are largely at 
the periphery of the debate on GMOs in Africa.
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Key Message for Policymakers
The development and implementation 
of robust and credible GMO policies 
and regulatory instruments require both 
effective scientific advisory systems and the 
appropriate use of peer-reviewed scientific 
evidence and advice on risks and benefits 
by African policymakers. Professional 
bodies should be actively engaged in the 
debate and decision-making on GMOs.
In most of Africa, the debate on GMOs 
is influenced by perceptions and is not 
based on sound knowledge of risks and/
or benefits. Emotive factors generally 
influence the debate and little consideration 
is given to science to inform decision-
making. Public leaders and opinion shapers 
(particularly the media/journalists) have 
not been well educated on the risks and 
benefits of biotechnology and GMOs. In 
some countries, regulators and decision-
makers are not trusted by the general 
public, as many of them are opposed to the 
introduction and/or commercialisation of 
GMOs. 
In many countries the tendency of 
policymakers is not to make decisions. 
This exacerbates the debate, as well as 
public anxiety and denies the countries 
opportunities of learning through risk 
assessment and management. 
“Activists propaganda alike overwhelms 
the public with selected details and 
slanted interpretations that make it 
difficult to separate the facts about 
genetically modified crops from the 
ideology. The public relations strategy 
of industry has been to link reassuring 
lab-coated scientists emphasising the fear 
of unknown consequences, while also 
claiming the moral high ground of progress 
with traditional family farm values. The 
opposition has consistently nipped at the 
heels of industry, harping on the same 
family farm. In the end, it becomes a 
question of whose lobby is more effective. 
So far, critics are winning the public’s 
attention while industry has triumphed in 
the regulatory arena.”17 
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the mistrust and policy inaction contribute 
to lower public acceptance of gMos 
and deny many Africans access to food in 
situations of hunger. When governments 
fail to ensure that people have access to 
safe GM food, they are undermining the 
constitutional rights of citizens.
Key Message for Policymakers
Policymakers should avoid reliance on 
perceptions of risks and rather deploy expert 
risk assessment and scientific advice in 
decision-making. It should be ensured that 
citizens have access to safe food, and GM 
technology helps ensure that access.
GOVERNANCE OF 
AGRICULTURAL 
BIOTECHNOLOGY IN AFRICA
Overview
A growing number of African countries are 
putting in place policies, laws and regulations 
to govern the development, use and 
commercialisation of GMOs. The state or 
level of development and application of these 
instruments varies from country to country. 
As signatories of the Cartagena Protocol 
on Biosafety, most of the African countries 
are required to put in place appropriate 
and effective legal and administrative 
structures or measures in order to implement 
the Protocol effectively. These legal and 
administrative structures can be built on 
existing structures, or they can be based on 
new frameworks.18 Countries are required 
to ensure that the development, handling, 
transport, use, transfer and release of any 
living modified organisms are done in a way 
that protects or reduce risks to human health 
and the biological diversity.19
By mid-2009:
• eleven African countries had developed 
and adopted national biosafety 
frameworks. These countries are Algeria, 
Burkina Faso, Egypt, Kenya, Mali, 
Mauritius, South Africa, Sudan, Togo, 
Tunisia and Zimbabwe; and
• twelve countries had interim frameworks 
(Cameroon, Ethiopia, Ghana, 
Madagascar, Malawi, Mozambique, 
Namibia, Nigeria, Senegal, Tanzania, 
Uganda and Zambia).20
By late 2011:
• fourteen African countries had full 
legislation on GMOs (Burkina Faso, 
Cameroon, Ethiopia, Kenya, Mali, 
Mozambique, Malawi, Mauritius, 
Namibia, Senegal, Tanzania Togo, 
Zambia and Zimbabwe).
Some of the African countries that have 
not developed and adopted explicit 
biosafety laws and regulations have implicit 
instruments, such as national environment 
regulations, food and drugs laws, and 
plant quarantine laws. These instruments 
have provisions that can be invoked to 
regulate the development, importation and 
commercialisation of GMOs.
Many of the biosafety laws of African 
countries have the following shortfalls:
1. They all put too much emphasis 
on regulating the importation and/
or introduction of GMOs developed 
elsewhere into the country. The laws are 
either silent on measures to regulate 
and promote domestic scientific 
research or just make passing reference 
to scientific research to locally develop 
GM crops.
2. They do not have explicit measures 
for promoting research on biosafety 
in general and risk assessment in 
particular.
3. They have provisions on public 
participation in GM regulatory 
processes, but do not articulate specific 
institutional mechanisms for ensuring 
that the participation takes place.
4. They recognise the importance of 
science-based decision-making, but 
are silent on specific measures to be 
followed to procure and ensure the use 
of credible scientific evidence.
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5. They put emphasis on issues of 
liability and redress based on an 
assumption that the technology is 
to be introduced from outside the 
country. 
6. There is an assumption on the 
part of most legal frameworks that 
the process of GM modification is 
somehow inherently risky and that 
this is contributing to a perceived 
need for strict liability. This 
perception does not reflect current 
practice and reality. 
7. They do not clearly consider the 
potential benefits of GMOs or 
the negative aspects of current 
agricultural practices.
Implementation of Biosafety 
Regimes: an Overall Assessment
African countries that have enacted laws 
and adopted regulations on biosafety 
have different experiences in ensuring 
efficient and effective implementation 
of the various provisions of these 
instruments. They also have different 
implementation capacities. However, 
they all face common or similar 
challenges. 
Key common challenges include:
1 high costs of gM research and 
development of products, and 
high costs of ensuring regulatory 
compliance. These high costs may 
be deterring local enterprises or 
companies from undertaking GM 
research and commercialisation.  
2 limited capacity to assess and 
determine the nature, as well 
as range, of uncertainties about 
potential benefits and risks of 
gMos. Most of the countries do 
not possess expertise in technology 
assessment and appraisal of risks.
3 limited capacity of national 
biosafety authorities and legal 
frameworks to effectively engage 
the public in informed decision-
making. In most African countries 
biosafety offices have not established 
institutional mechanisms for informed 
public participation in GM decision-
making. This is despite the national 
laws having provisions requiring 
public participation. 
SCIENCE AND THE ROLE OF 
NATIONAL ACADEMIES IN 
DECISION-MAKING
African policymakers and regulators 
are increasingly required to make 
complex decisions on the development, 
introduction, import, export and 
diffusion of GMOs in agriculture. As 
stated earlier, most of the time they have 
to make these decisions in the face of 
crisis and without access to evidence-
based analysis on the impacts of GMOs. 
They are confronted by strong pressures 
from pro-GMO and anti-GMO activists 
who wish to influence decision-making. 
Under these circumstances, African 
policymakers and regulators are still 
expected to make robust decisions in 
legitimate and efficient ways.
In many African countries, policymakers 
are not constitutionally or legally obliged 
to base their decisions on scientific 
evidence of the impacts of GMOs. 
They also do not have mechanisms, 
including mandatory guidelines, for the 
procurement and use of scientific advice. 
Institutional arrangements for decision-
making on GMOs are characterised by:
• absence of independent scientific 
advisory councils or panels whose 
members are actively engaged in 
the science of biotechnology and 
research on biosafety;
• absence of scientific advisory offices 
in key bodies such as presidencies, 
prime ministers’ offices and even 
ministries such as trade and industry, 
agriculture; 
• inconsistencies in and discontinuity of 
policy processes, often decisions are 
made under conditions of crisis;
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• limited public participation in and 
ownership of regulatory processes;
• limited public awareness of genetic 
modification and GMOs;
• relatively low funding for and weak 
scientific capacities in national regulatory 
agencies; and
• lack of mandatory guidelines for the 
collection, review and use of scientific 
advice.
Key Message for Policymakers
If procured and used well, science provides 
the means to legitimate and efficient 
decision-making on GMOs. It is the 
foundation for evidence-based, non-partisan 
and consistent policies on GMOs. 
National academies of science can play 
critical roles in the promotion of efficient 
GM regulation and innovation. They 
can be the main sources of independent 
credible scientific expertise and evidence 
for decision-making. However, as stated 
earlier, most African academies are not 
actively engaged in the provision of scientific 
evidence for and advice on the regulation of 
GMOs. 
There are 17 African national academies 
of science: Cameroon, Egypt, Ethiopia, 
Ghana, Kenya, Madagascar, Mauritius, 
Morocco, Mozambique, Nigeria, Senegal, 
South Africa, Sudan, Tanzania, Uganda, 
Zambia and Zimbabwe. There is one 
regional academy, the African Academy of 
Sciences (AAS), and a regional network of 
academies, the Network of African Science 
Academies (NASAC). Only two national 
academies have been involved in GMO 
policymaking, biosafety and regulatory 
processes in Africa.
National Academies involved in 
Biosafety Activities  
The Academy of Science of South Africa 
(ASSAf):
• Established a Standing Committee on 
Biosafety and Biosecurity to investigate 
mechanisms to regulate the conduct 
of safe science in South Africa; to 
raise the awareness of scientists about 
impacts of technology; and to assess 
the capacity of national laboratories to 
implement biosafety measures.
The Uganda National Academy of 
Sciences (UNAS):
• After the approval of the National 
Biotechnology and Biosafety Policy by 
Cabinet in 2008, UNAS convened a 
multidisciplinary committee of experts 
to clarify the overlap of biosafety and 
biosecurity. This was done in an effort 
to better position government officials 
as they weigh the pros and cons of 
government intervention in laboratories 
and the kinds of regulatory frameworks 
that might be implemented to ensure 
safe and secure labs while minimising 
undue burdens. 
• In 2010, UNAS released a report, The 
Scope of Biosafety and Biosecurity in 
Uganda: Policy Recommendations for 
the Control of Associated Risks. This 
report helped to provide conceptual 
clarity on differences between biosafety 
and biosecurity. It informed the 
national biosafety bill.
In other regions and countries of the world, 
science academies are actively engaged in 
research and regulatory activities on GM 
crops and GM in general. For example, in 
China the Chinese Academy of Sciences 
not only funds research on GM crops, but 
also has its own research activities. It is a 
very influential actor in the country’s GM 
regulatory system. Nearly all members of 
the scientific panels for biosafety are also 
members of the Academy. The Academy 
has also established specific policy institutes 
that are sources of evidence-based advice 
to the government. One of the institutes 
is the Centre for Agricultural Policy which 
undertakes research on socio-economic 
impacts of biotechnology.
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In Europe, the European Academies 
Science Advisory Council (EASAC) 
has been instrumental in producing 
studies that demonstrate benefits of 
GM in general and GM crops. For 
example, in 2003 they launched a 
study on the contributions of genomics 
research and its advantages compared 
to conventional crop breeding 
techniques.21 The EASAC is considered 
an authoritative source of advice, 
despite European politicians’ reluctance 
to openly promote GM crop adoption 
because of strong opposition to GM by 
deep ecology movements. 
Key Message for Policymakers
African policymakers should contribute 
to the strengthening of national and 
regional science academies to allow 
them to effectively participate in GM 
research and regulatory processes. 
IMPROVING GMO 
POLICYMAKING IN AFRICA
Summary of Issues and Key 
Messages for Policymakers
There are many stakeholders with 
many different interests involved in 
the debate and decision-making 
on GMOs. These include farmers, 
multinational companies, politicians, 
scientists, regulators, religious groups, 
environmentalists, and activists from 
different professional backgrounds and 
social groups. Managing the different 
interests and expectations is one of the 
challenges of GMO decision-making. In 
addition to the complexity associated with 
the many diverse stakeholders:
• GMO decision-making is laden 
with many scientific, ethical, social 
and economic issues. The science 
of genetic engineering and scientific 
issues associated with risk assessment 
and management are also complex. 
Different societal groups have 
different ethical considerations based 
on religion and culture; and
• the locus of decision-making 
is diffused. In most countries, 
decision-making is spread across 
the institutional terrain, involving 
different ministries e.g. agriculture, 
environment, trade and commerce, 
industry, and science and technology. 
These ministries often compete for 
authority, resources and even public 
recognition. Each seeks to be the 
locus of decision-making authority.
Because of the above factors or 
considerations, policymaking on GMO 
issues should be guided by the following 
principles:
• GMOs are not a homogenous group 
or category of products. Each GMO 
is specific in content, application and 
impact. Each GM crop or product 
should be evaluated independently 
within a consistent set of applied 
standards and regulations;
• decision-making on GMOs should be 
participatory, trans-organisational, 
transparent, have a multidisciplinary 
approach that encompasses natural 
sciences, social sciences and 
humanities, where appropriate;
• decision-making should be flexible 
and done on a case-by-case basis 
allowing for revision of decisions as 
and when new credible evidence or 
information is available; and
• an ability to adjust regulatory 
frameworks and guidelines in the 
light of new evidence should be 
regarded as a strength rather than a 
weakness.
In most African countries the credibility, 
in terms of robustness and legitimacy, 
of executive or government decisions on 
GMOs is often questioned because of 
the absence of independent scientific 
advice or input into decision-making. 
Government departments or national 
biosafety authorities responsible for 
regulating the development, introduction 
and commercialisation of GMOs tend 
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to rely on their in-house experts and/
or scientific advisory committees that are 
constituted without informed public input 
and peer reference.1
Key Messages for African National 
Academies of Science 
The African national academies of science 
can:
• be instrumental in supporting 
governments in general and national 
biosafety authorities to identify and 
appoint the best available experts to 
serve on advisory committees and 
panels; and
• engage in activities and processes 
that raise public awareness of and 
confidence in biotechnology in general 
and GMOs in particular. At the moment 
the academies are not playing these 
roles, at least not actively and effectively.
Academies should:
1. establish an inter-academies’ 
programme on agricultural 
biotechnology. They should design 
and implement a programme on 
biotechnology, with emphasis on the 
following aspects:
• networking and supporting African 
scientists who are engaged in cutting- 
edge research on genetic modification 
and risk assessment; 
• monitoring global trends in the science 
of genetic modification and related 
technological developments; 
• informing the public and policymakers 
of the scientific and technological 
advances through newsletters and 
other media platforms, and this should 
be done through proper strategic plans 
for information flow and dissemination; 
• interpreting the integrity and safety 
implications or lack thereof of studies 
as they get published; and 
• conducting review studies on the 
diffusion of biotechnology and GMOs 
in Africa.
2. help in building public awareness of 
and confidence (through the availability 
of credible information) in genetic 
modification for improved agriculture 
and food security. The African public is 
poorly informed on issues concerning 
the science and impacts of biotechnology 
in general and genetic engineering 
in particular. The academies should 
contribute to the raising of public 
awareness through:
• ensuring school curricula adequately 
deal with the topic of biotechnology 
to educate the next generation of 
scientists, technology developers, risk 
assessors and regulators;
• producing popular readers on genetic 
engineering and GMOs, organising 
public consensus building workshops, 
organising training workshops for 
journalists and other activities that will 
help better communicate information 
on the science of genetic engineering 
and GMOs;
• designing and delivering of public 
participation processes that improve 
public policies on GMOs and 
agriculture, providing the public 
access to information from scientists, 
giving scientists information from 
the public, and allowing careful 
consideration of alternatives.
3. Support the establishment of databases 
or databanks of experts and relevant 
scientific research activities. They 
can support policymakers to be aware 
of and use the best available experts 
and sources of scientific evidence by 
developing databanks or databases of 
experts and research activities and then 
disseminating this information to national 
biosafety authorities and policymakers.
4. establish links with other academies 
outside of africa, especially with 
countries that have interests in the 
development and deployment of GM 
crops. Also, to use these links to share 
information and experience.
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CONCLUSIONS
It is clear that there is an urgent need 
to mobilise and use scientific advice 
from all reputable sources in GM 
technology decision-making in Africa. 
In addition, effective and informed 
public participation will ensure that 
these decisions are more inclusive and 
widely accepted. It has been shown that 
while African countries are exposed to 
GM technologies and products, they 
are not effectively harnessing these 
to solve problems of food production. 
The leadership of African policymakers 
and scientists is urgently needed to 
promote technological innovation and 
the adoption of GM crops in order to 
increase agricultural production and 
enhance prospects of food security on 
the continent.
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